Showing results (11-20 of 509) with videos related to
Sort By:
Pageof 51
Neuropsychiatric Disease and Treatment|June 10, 2011
Once-daily pramipexole for the treatment of early and advanced idiopathic Parkinson's disease: implications for patientsAngelo Antonini, Daniela CalandrellaThe Lancet. Neurology|August 21, 2007
Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's diseaseAngelo Antonini, Werner PoeweParkinsonism & Related Disorders|December 15, 2011
Pulsatile or continuous dopaminomimetic strategies in Parkinson's diseaseDaniela Calandrella, Angelo AntoniniExpert Review of Neurotherapeutics|June 10, 2011
Pathological gambling in Parkinson's disease: disease related or drug related?Daniela Calandrella, Angelo AntoniniExpert Opinion on Drug Metabolism & Toxicology|September 7, 2011
Pharmacokinetic evaluation of pramipexoleAngelo Antonini, Daniela CalandrellaExpert Review of Neurotherapeutics|June 6, 2009
Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient managementAngelo Antonini, Eduardo TolosaSleep Medicine|March 23, 2004
PET and SPECT functional imaging in Parkinson's diseaseAngelo Antonini, Roberta DeNotarisExpert Review of Neurotherapeutics|January 17, 2014
Novel levodopa formulations in the treatment of Parkinson's diseaseManuela Pilleri, Angelo AntoniniExpert Opinion on Drug Safety|December 9, 2014
Therapeutic strategies to prevent and manage dyskinesias in Parkinson's diseaseManuela Pilleri, Angelo AntoniniJournal of Neural Transmission (Vienna, Austria : 1996)|July 15, 2018
Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson diseaseAngelo Antonini, Bianca NituPageof 51